On Wednesday, Shares of Frontier Communications Corporation (NASDAQ:FTR), lost -0.39% to $5.07.
Frontier Secure, a service of FTR, said that it’s offering high-speed Internet customers Nest thermostats.
Nest is a smart, energy-saving thermostat that can remember what temperature customers like, and can program itself. It can also be controlled with the smartphone, as users can adjust the temperature from anywhere at anytime.
The offer will be for new and existing Frontier Communications customers. Those who are upgrading their speed can get the Nest Learning Thermostat for $99, instead of its original price, $249.99.
“The Internet has become so much more than smartphones, tablets and computers,” Frontier Secure’s VP Kelly Morgan said. “As the gatekeeper to the digital world for our customers, we take pride in enhancing our customers’ digital lives and assisting them save energy and money with the Nest Thermostat.”
Frontier Communications Corporation, a communications company, provides regulated and unregulated voice, data, and video services to residential, business, and wholesale customers in the United States.
Health care stocks dropped in afternoon trade Wednesday, with the NYSE Health Care Sector Index slumping about 0.5% and shares of health care companies in the S&P 500 down over 0.6% as a group.
Among Health care stocks, Shares of Gilead Sciences Inc. (NASDAQ:GILD), declined -0.16% to $122.01, during its last trading session.
Gilead Sciences, has witnessed a drop of 18% or 7,884,277 shares in its short figure. The short interest diminution took it from 43,702,981 on May 29,2015 to 35,818,704 on June 15,2015. In terms of floated shares, the short interest was calculated to be 2.5%. The days to cover are 4 given that the daily volume averaged 10,157,854 shares. The information was released by Financial Industry Regulatory Authority, Inc (FINRA) on June 24th.
Argus set a $150.00 price target on Gilead Sciences, in a research note issued to investors on Tuesday. The firm presently has a a buy rating on the biopharmaceutical company’s stock.
In other Gilead Sciences news, EVP Paul Rutherford Carter sold 10,000 shares of the company’s stock in a transaction dated Thursday, June 18th. The shares were sold at an average price of $120.00, for a total transaction of $1,200,000.00. The transaction was revealed in a filing with the SEC.
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in areas of unmet medical need in North America, South America, Europe, and the Asia-Pacific.
Finally, American Express Company (NYSE:AXP), ended its last trade with -0.76% loss, and closed at $80.74.
American Express Co. has promoted Steve Squeri to vice chairman and reorganized some of its top roles in the wake of the death of President Edward Gilligan in late May, according to WSJ.
Squeri, 56, will assume responsibility for the firm’s small-business initiative and enterprise growth, in addition to continue to oversee global corporate payments and the global services group, the New York-based lender said Wednesday in a statement. Bloomberg Reports.
Gilligan, a 35-year AmEx veteran who was seen as a candidate to eventually run the company, died May 29 on a return trip from Tokyo after suffering an embolism and subsequent heart attack, a person briefed on the matter has said. Squeri’s expanded role means he’s viewed as Chenault’s No. 2 and next in line as a possible successor, according to analysts counting Janney Montgomery Scott’s Sameer Gokhale. Bloomberg added.
American Express Company, together with its auxiliaries, provides charge and credit payment card products and travel-related services to consumers and businesses worldwide. The company operates through four segments: U.S. Card Services, International Card Services, Global Commercial Services, and Global Network & Merchant Services.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should/might occur.
